Metraipolis › archive › dc_6d93f3a93095

Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge — Europe PMC PMID:32407410

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32407410
DOI
10.1371/journal.pone.0232234
License (as archived)
CC0-1.0
Archived
2026-11-08T18:08:14.935Z
SHA-256 of the archived text
b8042a9dd18c5cc25778c785c83035d8fc9e3f01c7d6363ccdb337b656e671d5
Stable URL of this page
https://metraipolis.com/documento/dc_6d93f3a93095

How to cite

Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge — Europe PMC PMID:32407410 — Europe PMC (en), https://europepmc.org/article/MED/32407410 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_6d93f3a93095 (Metraipolis archive dc_6d93f3a93095, sha256 b8042a9dd18c5cc25778c785c83035d8fc9e3f01c7d6363ccdb337b656e671d5)
BibTeX
@misc{dc6d93f3a93095,
  title = {Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge — Europe PMC PMID:32407410},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32407410},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_6d93f3a93095; sha256 b8042a9dd18c5cc25778c785c83035d8fc9e3f01c7d6363ccdb337b656e671d5},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32407410. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Only a small fraction of the antigens expressed by malaria parasites have been evaluated as vaccine candidates. A successful malaria subunit vaccine will likely require multiple antigenic targets to achieve broad protection with high protective efficacy. Here we describe protective efficacy of a novel antigen, Plasmodium yoelii (Py) E140 (PyE140), evaluated against P. yoelii challenge of mice. Vaccines targeting PyE140 reproducibly induced up to 100% sterile protection in both inbred and outbred murine challenge models. Although PyE140 immunization induced high frequency and multifunctional CD8+ T cell responses, as well as CD4+ T cell responses, protection was mediated by PyE140 antibodies acting against blood stage parasites. Protection in mice was long-lasting with up to 100% sterile protection at twelve weeks post-immunization and durable high titer anti-PyE140 antibodies. The E140 antigen is expressed in all Plasmodium species, is highly conserved in both P. falciparum lab-adapted strains and endemic circulating parasites, and is thus a promising lead vaccine candidate for future evaluation against human malaria parasite species.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-05-14).
Identificativi: PMID 32407410 · PMCID PMC7224506 · DOI 10.1371/journal.pone.0232234.
Descrittori MeSH principali: Immunization.
Pagina: https://europepmc.org/article/MED/32407410 — https://doi.org/10.1371/journal.pone.0232234. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T18:04:48.391Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.